BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26239796)

  • 1. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
    ; Jaff MR; White CJ; Hiatt WR; Fowkes GR; Dormandy J; Razavi M; Reekers J; Norgren L
    J Endovasc Ther; 2015 Oct; 22(5):663-77. PubMed ID: 26239796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
    ; Jaff MR; White CJ; Hiatt WR; Fowkes GR; Dormandy J; Razavi M; Reekers J; Norgren L
    Vasc Med; 2015 Oct; 20(5):465-78. PubMed ID: 26268268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee.
    Jaff MR; White CJ; Hiatt WR; Fowkes GR; Dormandy J; Razavi M; Reekers J; Norgren L
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):611-25. PubMed ID: 26256456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee(.).
    Jaff MR; White CJ; Hiatt WR; Fowkes GR; Dormandy J; Razavi M; Reekers J; Norgren L
    Ann Vasc Dis; 2015; 8(4):343-57. PubMed ID: 26730266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary: TASC II Anatomic Classification for Infrapopliteal Arterial Disease: A Framework for Clinical Practice and Future Research.
    Antoniou GA; Ibrahim R; Ahmad N; Torella F
    J Endovasc Ther; 2015 Oct; 22(5):678-80. PubMed ID: 26239797
    [No Abstract]   [Full Text] [Related]  

  • 6. Internal Iliac Artery Disease Management: Still Absent in the Update to TASC II (Inter-Society Consensus for the Management of Peripheral Arterial Disease).
    Mahé G; Kaladji A; Le Faucheur A; Jaquinandi V
    J Endovasc Ther; 2016 Feb; 23(1):233-4. PubMed ID: 26763263
    [No Abstract]   [Full Text] [Related]  

  • 7. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    JACC Cardiovasc Interv; 2014 Jul; 7(7):792-8. PubMed ID: 25060024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.
    ; Conte MS; Pomposelli FB; Clair DG; Geraghty PJ; McKinsey JF; Mills JL; Moneta GL; Murad MH; Powell RJ; Reed AB; Schanzer A; Sidawy AN;
    J Vasc Surg; 2015 Mar; 61(3 Suppl):2S-41S. PubMed ID: 25638515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of endovascular treatment for infrapopliteal peripheral artery disease based on the updated TASC II classification.
    Müller AM; Räpple V; Bradaric C; Koppara T; Kehl V; Fusaro M; Cassese S; Ott I; Kastrati A; Laugwitz KL; Ibrahim T
    Vasc Med; 2021 Feb; 26(1):18-25. PubMed ID: 33256573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCAI expert consensus statement for aorto-iliac arterial intervention appropriate use.
    Klein AJ; Feldman DN; Aronow HD; Gray BH; Gupta K; Gigliotti OS; Jaff MR; Bersin RM; White CJ;
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):520-8. PubMed ID: 24740523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use.
    Gray BH; Diaz-Sandoval LJ; Dieter RS; Jaff MR; White CJ;
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):539-45. PubMed ID: 25045160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. German guideline on the diagnosis and treatment of peripheral artery disease - a comprehensive update 2016.
    Lawall H; Huppert P; Espinola-Klein C; Zemmrich CS; Ruemenapf G
    Vasa; 2017 Mar; 46(2):79-86. PubMed ID: 28128018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the endovascular treatment of intermittent claudication: rationale for changes in the TASC classification.
    White JV; Ryjewski C
    Semin Vasc Surg; 2007 Mar; 20(1):54-61. PubMed ID: 17386364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCAI expert consensus statement for femoral-popliteal arterial intervention appropriate use.
    Klein AJ; Pinto DS; Gray BH; Jaff MR; White CJ; Drachman DE;
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):529-38. PubMed ID: 24753020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of demographic factors and lesion severity on iliac stent patency.
    Roach AN; Larion S; Ahanchi SS; Ammar CP; Brandt CT; Dexter DJ; Panneton JM
    J Vasc Surg; 2015 Sep; 62(3):645-53. PubMed ID: 26094046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions.
    Piazza M; Squizzato F; Spolverato G; Milan L; Bonvini S; Menegolo M; Grego F; Antonello M
    J Vasc Surg; 2015 Nov; 62(5):1210-8.e1. PubMed ID: 26254822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stent-based revascularization for complex lesions in PAD.
    d'SOUZA J; Giri J; Kobayashi T
    J Cardiovasc Surg (Torino); 2017 Oct; 58(5):715-721. PubMed ID: 28471154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TASC II and the endovascular management of infrainguinal disease.
    Lyden SP; Smouse HB
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II5-18. PubMed ID: 19624072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center.
    Grenville JL; Tan KT; Moshonov H; Rajan DK
    Vascular; 2015 Feb; 23(1):31-40. PubMed ID: 24695358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SICI-GISE position paper on the requirements for diagnostic and interventional procedures in patients with peripheral arterial disease].
    Cremonesi A; Setacci C; Rubino P; Stabile E; Castriota F; Reimers B; Inglese L; Berti S; Sbarzaglia P; Biamino G; Guagliumi G;
    G Ital Cardiol (Rome); 2013 Oct; 14(10):690-8. PubMed ID: 24121895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.